MedTrace Pharma A/S — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
[O-15]-Water PET Myocardial Perfusion Imaging (MPI)This a Phase 3, prospective, open-label, multicenter study of \[15-O\]-H2O injection for PET imaging of subjects with suspected CAD. Approximately 182 evaluable participants with suspected CAD referred for testing will be included in the study at approximately 10 study sites in the United States and Europe. Approximately 215 participants will be enrolled to account for an estimated 15% drop-out rate. Screening assessments will occur prior to enrollment to confirm eligibility. All participants will receive two doses of \[15-O\]-H2O as part of a single PET imaging session (one dose at rest and one during pharmacological stress with adenosine). A safety follow-up phone call will occur 24 ± 8 hrs after completion of the \[15-O\]-H2O scan.	Maladie coronarienne	Phase 3	À vérifier	United States, Canada, Denmark, Germany, Netherlands, Sweden	À vérifier
[O-15]-Water PET Myocardial Perfusion Imaging (MPI)This a Phase 3, prospective, open-label, multicenter study of \[15-O\]-H2O injection for PET imaging of subjects with suspected CAD. Approximately 182 evaluable participants with suspected CAD referred for testing will be included in the study at approximately 10 study sites in the United States and Europe. Approximately 215 participants will be enrolled to account for an estimated 15% drop-out rate. Screening assessments will occur prior to enrollment to confirm eligibility. All participants will receive two doses of \[15-O\]-H2O as part of a single PET imaging session (one dose at rest and one during pharmacological stress with adenosine). A safety follow-up phone call will occur 24 ± 8 hrs after completion of the \[15-O\]-H2O scan.	Maladie coronarienne	Phase 3	À vérifier	United States, Canada, Denmark, Germany, Netherlands, Sweden	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
[O-15]-Water PET Myocardial Perfusion Imaging (MPI)	Maladie coronarienne	Phase 3	NCT05134012	RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)	COMPLETED

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.